Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


1 Ann Oncol
1 Ann Surg Oncol
6 BMC Cancer
2 Br J Cancer
4 Breast Cancer
6 Breast Cancer (Auckl)
2 Breast Cancer (Dove Med Press)
11 Breast Cancer Res Treat
1 Breast J
2 Cancer
3 Cancer Cell
2 Cancer Res
3 Clin Breast Cancer
5 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Cancer
2 Eur J Surg Oncol
1 Gene
1 Genes Chromosomes Cancer
3 Int J Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Nucl Med
1 Lancet Oncol
1 Nature
1 NPJ Breast Cancer
1 Oncol Rep
4 PLoS One
1 Radiology

    Ann Oncol

  1. MARTIN M, Campone M, Bondarenko I, Sakaeva D, et al
    Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.
    Ann Oncol. 2018 Feb 10. pii: 4852792. doi: 10.1093.
    >> Share

    Ann Surg Oncol

  2. MAMTANI A, Gonzalez JJ, Neo DT, Friedman RS, et al
    Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer.
    Ann Surg Oncol. 2018 Feb 9. pii: 10.1245/s10434-018-6350.
    >> Share

    BMC Cancer

  3. AL DOSSARY R, Alkharsah KR, Kussaibi H
    Prevalence of Mouse Mammary Tumor Virus (MMTV)-like sequences in human breast cancer tissues and adjacent normal breast tissues in Saudi Arabia.
    BMC Cancer. 2018;18:170.
    >> Share

  4. LAFOURCADE A, His M, Baglietto L, Boutron-Ruault MC, et al
    Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort.
    BMC Cancer. 2018;18:171.
    >> Share

  5. NGUYEN-DUMONT T, Teo ZL, Hammet F, Roberge A, et al
    Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
    BMC Cancer. 2018;18:165.
    >> Share

  6. GAO D, Cazares LH, Fish EN
    CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
    BMC Cancer. 2017;17:834.
    >> Share

  7. WU Y, Zhang N, Yang Q
    The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
    BMC Cancer. 2017;17:839.
    >> Share

  8. SIRISENA ND, Adeyemo A, Kuruppu AI, Neththikumara N, et al
    Genetic determinants of sporadic breast cancer in Sri Lankan women.
    BMC Cancer. 2018;18:180.
    >> Share

    Br J Cancer

  9. HSIEH WH, Lin IF, Ho JC, Chang PW, et al
    Reply to 'Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure''.
    Br J Cancer. 2018 Feb 13. pii: bjc2017490. doi: 10.1038/bjc.2017.
    >> Share

  10. DOSS M
    Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure'.
    Br J Cancer. 2018 Feb 13. pii: bjc2017481. doi: 10.1038/bjc.2017.
    >> Share

    Breast Cancer

  11. CHEN W, Lv X, Xu X, Gao X, et al
    Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer.
    Breast Cancer. 2018 Feb 13. pii: 10.1007/s12282-018-0846.
    >> Share

  12. MASUDA N, Toi M, Yamamoto N, Iwata H, et al
    Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicent
    Breast Cancer. 2018 Feb 14. pii: 10.1007/s12282-018-0839.
    >> Share

  13. OHTANI S, Nakayama T, Yoshinami T, Watanabe KI, et al
    Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
    Breast Cancer. 2018 Feb 12. pii: 10.1007/s12282-018-0843.
    >> Share

  14. SURYAVANSHI M, Mehta A, Jaipuria J, Kumar D, et al
    Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.
    Breast Cancer. 2018 Feb 9. pii: 10.1007/s12282-018-0840.
    >> Share

    Breast Cancer (Auckl)

  15. ZEICHNER SB, Zeichner RL, Gogineni K, Shatil S, et al
    Cognitive Behavioral Therapy for Insomnia, Mindfulness, and Yoga in Patients With Breast Cancer with Sleep Disturbance: A Literature Review.
    Breast Cancer (Auckl). 2017;11:1178223417745564.
    >> Share

  16. BERGER A, Regueiro C, Hijal T, Pasquier D, et al
    Interest of Supportive and Barrier Protective Skin Care Products in the Daily Prevention and Treatment of Cutaneous Toxicity During Radiotherapy for Breast Cancer.
    Breast Cancer (Auckl). 2018;12:1178223417752772.
    >> Share

  17. RIVERA-FRANCO MM, Leon-Rodriguez E
    Delays in Breast Cancer Detection and Treatment in Developing Countries.
    Breast Cancer (Auckl). 2018;12:1178223417752677.
    >> Share

  18. SINGH S, Murillo G, Chen D, Parihar AS, et al
    Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3.
    Breast Cancer (Auckl). 2018;12:1178223417750858.
    >> Share

  19. ATOUM M, Alzoughool F
    Vitamin D and Breast Cancer: Latest Evidence and Future Steps.
    Breast Cancer (Auckl). 2017;11:1178223417749816.
    >> Share

  20. MILLS RC 3RD
    Breast Cancer Survivors, Common Markers of Inflammation, and Exercise: A Narrative Review.
    Breast Cancer (Auckl). 2017;11:1178223417743976.
    >> Share

    Breast Cancer (Dove Med Press)

  21. NISKA JR, Keole SR, Pockaj BA, Halyard MY, et al
    Choosing wisely after publication of level I evidence in breast cancer radiotherapy.
    Breast Cancer (Dove Med Press). 2018;10:31-37.
    >> Share

  22. CRISCITIELLO C, Viale G, Curigliano G, Goldhirsch A, et al
    Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date.
    Breast Cancer (Dove Med Press). 2018;10:23-29.
    >> Share

    Breast Cancer Res Treat

  23. CHANG JH, Shin KH, Ahn SD, Park HJ, et al
    Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy.
    Breast Cancer Res Treat. 2018 Feb 12. pii: 10.1007/s10549-018-4707.
    >> Share

  24. SHOEMAKER ML, White MC, Wu M, Weir HK, et al
    Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013.
    Breast Cancer Res Treat. 2018 Feb 14. pii: 10.1007/s10549-018-4699.
    >> Share

  25. GIANNAKEAS V, Sopik V, Narod SA
    A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis.
    Breast Cancer Res Treat. 2018 Feb 14. pii: 10.1007/s10549-018-4716.
    >> Share

  26. COLLARINO A, Valdes Olmos RA, van Berkel LGAJ, Neijenhuis PA, et al
    The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.
    Breast Cancer Res Treat. 2018 Feb 13. pii: 10.1007/s10549-018-4706.
    >> Share

  27. XIE B, Yuan Z, Yang Y, Sun Z, et al
    MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine.
    Breast Cancer Res Treat. 2018 Feb 10. pii: 10.1007/s10549-018-4708.
    >> Share

  28. DE MULDER H, Laenen A, Wildiers H, Punie K, et al
    Breast cancer subtype and survival by parity and time since last birth.
    Breast Cancer Res Treat. 2018 Feb 10. pii: 10.1007/s10549-018-4701.
    >> Share

  29. DEHDASHTI F, Wu N, Bose R, Naughton MJ, et al
    Evaluation of [(89)Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
    Breast Cancer Res Treat. 2018 Feb 13. pii: 10.1007/s10549-018-4696.
    >> Share

  30. GOLDVASER H, Majeed H, Ribnikar D, Seruga B, et al
    Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis.
    Breast Cancer Res Treat. 2018 Feb 8. pii: 10.1007/s10549-018-4710.
    >> Share

  31. SKAANE P, Sebuodegard S, Bandos AI, Gur D, et al
    Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial.
    Breast Cancer Res Treat. 2018 Feb 10. pii: 10.1007/s10549-018-4705.
    >> Share

    Is invasion a necessary step for metastases in breast cancer? Narod SA, Sopik V.
    Breast Cancer Res Treat. 2018 Feb 12. pii: 10.1007/s10549-018-4702.
    >> Share

  33. MIYAKE KK, Nakamoto Y, Saji S, Sugie T, et al
    Impact of physiological hormonal fluctuations on (18)F-fluorodeoxyglucose uptake in breast cancer.
    Breast Cancer Res Treat. 2018 Feb 8. pii: 10.1007/s10549-018-4711.
    >> Share

    Breast J

  34. CAMPBELL A, Heydarian R, Ochoa C, Dwivedi AK, et al
    Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Breast J. 2018 Feb 14. doi: 10.1111/tbj.12951.
    >> Share


  35. KWA MJ, Adams S
    Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here.
    Cancer. 2018 Feb 9. doi: 10.1002/cncr.31272.
    >> Share

  36. EKENGA CC, Perez M, Margenthaler JA, Jeffe DB, et al
    Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls.
    Cancer. 2018 Feb 13. doi: 10.1002/cncr.31270.
    >> Share

    Cancer Cell

  37. LI CW, Lim SO, Chung EM, Kim YS, et al
    Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
    Cancer Cell. 2018;33:187-201.
    >> Share

  38. SALATINO M, Girotti MR, Rabinovich GA
    Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2018;33:155-157.
    >> Share

  39. MCDONNELL DP, Norris JD, Chang CY
    Neomorphic ERalpha Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery.
    Cancer Cell. 2018;33:153-155.
    >> Share

    Cancer Res

  40. HAO J, Yan F, Zhang Y, Triplett A, et al
    Expression of adipocyte/macrophage fatty acid binding protein in tumor associated macrophages promotes breast cancer progression.
    Cancer Res. 2018 Feb 6. pii: 0008-5472.CAN-17-2465.
    >> Share

  41. HORNSVELD M, Smits LM, Meerlo M, van Amersfoort M, et al
    FOXO transcription factors both suppress and support breast cancer progression.
    Cancer Res. 2018 Feb 12. pii: 0008-5472.CAN-17-2511.
    >> Share

    Clin Breast Cancer

  42. ERSOY YE, Kadioglu H
    Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
    >> Share

  43. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
    Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
    >> Share

  44. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
    Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
    >> Share

    Clin Cancer Res

  45. SHAH A, Bloomquist E, Tang S, Fu W, et al
    FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
    Clin Cancer Res. 2018 Feb 7. pii: 1078-0432.CCR-17-2369.
    >> Share

  46. MARTINS CD, Da Pieve C, Burley TA, Smith R, et al
    HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-based PET Imaging.
    Clin Cancer Res. 2018 Feb 6. pii: 1078-0432.CCR-17-2754.
    >> Share

  47. KABRAJI S, Ni J, Lin N, Xie S, et al
    Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?
    Clin Cancer Res. 2018 Feb 6. pii: 1078-0432.CCR-17-3351.
    >> Share

  48. HAMILTON EP, Patel MR, Armstrong AC, Baird RD, et al
    A first in human study of the new oral selective estrogen receptor degrader AZD9496 for HR+/HER2- advanced breast cancer.
    Clin Cancer Res. 2018 Feb 13. pii: 1078-0432.CCR-17-3102.
    >> Share

  49. KARAPANAGIOTIS S, Pharoah PDP, Jackson CH, Newcombe PJ, et al
    Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
    Clin Cancer Res. 2018 Feb 14. pii: 1078-0432.CCR-17-3542.
    >> Share

    Clin Exp Metastasis

  50. KASOHA M, Unger C, Solomayer EF, Bohle RM, et al
    Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
    Clin Exp Metastasis. 2018 Feb 10. pii: 10.1007/s10585-018-9878.
    >> Share

    Eur J Cancer

  51. PIVOT X, Bondarenko I, Nowecki Z, Dvorkin M, et al
    A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.
    Eur J Cancer. 2018;93:19-27.
    >> Share

    Eur J Surg Oncol

  52. ZHAO S, Ma D, Xiao Y, Jiang YZ, et al
    Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
    Eur J Surg Oncol. 2018 Jan 9. pii: S0748-7983(18)30002.
    >> Share

    Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30118.
    >> Share


  54. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    >> Share

    Genes Chromosomes Cancer

  55. FIMERELI D, Fumagalli D, Brown D, Gacquer D, et al
    Genomic hotspots but few recurrent fusion genes in breast cancer.
    Genes Chromosomes Cancer. 2018 Feb 13. doi: 10.1002/gcc.22533.
    >> Share

    Int J Oncol

  56. HAN Y, Fan S, Qin T, Yang J, et al
    Role of autophagy in breast cancer and breast cancer stem cells (Review).
    Int J Oncol. 2018 Feb 8. doi: 10.3892/ijo.2018.4270.
    >> Share

  57. CASTELLANOS-ESPARZA YC, Wu S, Huang L, Buquet C, et al
    Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells.
    Int J Oncol. 2018 Feb 9. doi: 10.3892/ijo.2018.4272.
    >> Share

  58. MAXWELL T, Lee KS, Kim S, Nam KS, et al
    Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells.
    Int J Oncol. 2018 Feb 9. doi: 10.3892/ijo.2018.4271.
    >> Share

    J Clin Oncol

  59. WAPNIR IL, Price KN, Anderson SJ, Robidoux A, et al
    Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
    J Clin Oncol. 2018 Feb 14:JCO2017765719. doi: 10.1200/JCO.2017.76.5719.
    >> Share

    J Natl Cancer Inst

  60. BROWN J, Rathbone E, Hinsley S, Gregory W, et al
    Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.
    J Natl Cancer Inst. 2018 Feb 7. pii: 4842040. doi: 10.1093.
    >> Share

    J Nucl Med

  61. HUMBERT O, Lasserre M, Bertaut A, Fumoleau P, et al
    Pattern of breast cancer blood flow and metabolism, assessed using dual-acquisition (18)FDG PET: correlation with tumor phenotypic features and pathological response to neoadjuvant chemotherapy.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.203075. doi: 10.2967/jnumed.117.203075.
    >> Share

    Lancet Oncol

  62. WILDIERS H, Tryfonidis K, Dal Lago L, Vuylsteke P, et al
    Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
    Lancet Oncol. 2018 Feb 9. pii: S1470-2045(18)30083.
    >> Share


  63. MICALIZZI DS, Maheswaran S
    On the trail of invasive cells in breast cancer.
    Nature. 2018;554:308-309.
    >> Share

    NPJ Breast Cancer

  64. SUNG H, Ren J, Li J, Pfeiffer RM, et al
    Breast cancer risk factors and mammographic density among high-risk women in urban China.
    NPJ Breast Cancer. 2018;4:3.
    >> Share

    Oncol Rep

  65. RATHINAVELU A, Kanagasabai T, Dhandayuthapani S, Alhazzani K, et al
    Anti-angiogenic and pro-apoptotic effects of a small-molecule JFD-WS in in vitro and breast cancer xenograft mouse models.
    Oncol Rep. 2018 Feb 9. doi: 10.3892/or.2018.6256.
    >> Share

    PLoS One

  66. CALA MP, Aldana J, Medina J, Sanchez J, et al
    Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
    PLoS One. 2018;13:e0190958.
    >> Share

  67. ROHAN T, Ye K, Wang Y, Glass AG, et al
    MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer.
    PLoS One. 2018;13:e0191814.
    >> Share

  68. YUAN H, Chen V, Boisvert M, Isaacs C, et al
    PLAC1 as a serum biomarker for breast cancer.
    PLoS One. 2018;13:e0192106.
    >> Share

  69. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    >> Share


  70. GUNTHER JE, Lim EA, Kim HK, Flexman M, et al
    Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Radiology. 2018 Feb 12:161041. doi: 10.1148/radiol.2018161041.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016